Aptiv Solutions provides drug development consulting and regulatory services essential to progress a development program from research to product approval.
Ricerca CEO Ian Lennox said the Fulcrum Pharma collaboration is an attractive and exciting proposition for Ricerca and their clients.
"Fulcrum Pharma brings deep experience in IND authorship and regulatory approval, which fits well with Ricerca’s preclinical services in discovery pharmacology, chemical development and drug safety assessment," Lennox said.